Certara acquires Pirana
Certara has announced that it has Pirana, a product for connecting and organising pharmacometric modelling results as well as providing interfaces to a range of software tools used in pharmacometrics modelling.
‘We are thrilled that Pirana, which has been used by our scientists for years, will now be part of the Certara technology portfolio,’ said Dr Thomas Kerbusch, president of Certara Strategic Consulting.
‘Our acquisition of Pirana affirms our commitment to creating a holistic, agnostic, efficient and impactful modelling and simulation ecosystem that leverages tools that exist today and those that will emerge in the future. We look forward to continued collaboration with Dr Keizer to advance Pirana and nurture a connected pharmacometric environment.’
Pirana is a flexible pharmacometrics workbench that provides users with structure, tools and a graphical user interface to facilitate the iterative processes used to create pharmacometric models and perform simulations. Those research tools include model templates and wizards, a library of goodness-of-fit plots (R), model translation tools, built-in support for version control and audit trails, and interfaces to other commonly-used pharmacometrics software products. Traceability and reproducibility are pivotal to validating modelling results and are hallmark Pirana benefits.
Dr Keizer said, ‘I am confident that Pirana has found the right home with Certara. Not only does Certara have a formidable arsenal of products for quantitative scientists, but it is the undisputed leader in educating the larger community about the myriad benefits that modelling and simulation can provide for today’s drug developers. The Pirana of today and the Pirana of tomorrow fit within that larger remit.’
Developed by Dr Ron Keizer, in 2007, Pirana is now available in both a desktop and cloud-based version.